Isoorientin: A dietary flavone with the potential to ameliorate diverse metabolic complications.
Diabetes
Inflammation
Isoorientin
Metabolic disease
Obesity
Oxidative stress
Journal
Pharmacological research
ISSN: 1096-1186
Titre abrégé: Pharmacol Res
Pays: Netherlands
ID NLM: 8907422
Informations de publication
Date de publication:
08 2020
08 2020
Historique:
received:
07
03
2020
revised:
24
04
2020
accepted:
26
04
2020
pubmed:
15
5
2020
medline:
5
6
2021
entrez:
15
5
2020
Statut:
ppublish
Résumé
Isoorientin is a natural C-glucosyl flavone that is generating a lot of interest due to its multiple pharmacological activities. Increasing experimental data have shown that the robust antioxidant and anti-inflammatory properties of isoorientin remain important in ameliorating a number of metabolic complications. In fact, plants rich in isoorientin have demonstrated strong ameliorative properties against complications such as hyperglycemia, hyperlipidemia, and insulin resistance. However, while such evidence is accumulating, it has not been reviewed to better inform on the therapeutic potential of this flavone in improving human health. This review examines and extrapolates available literature on the potential beneficial or detrimental effects associated with the use of isoorientin in mitigating metabolic diseases, with a specific focus on diabetes, obesity, and insulin resistance, including associated complications. The discussion includes effective doses in various experimental settings and proposed molecular mechanisms by which isoorientin may exert its therapeutic effects. In addition, the protective effects of extracts of a number of isoorientin-rich plants against metabolic complications will be highlighted.
Identifiants
pubmed: 32407953
pii: S1043-6618(20)31175-0
doi: 10.1016/j.phrs.2020.104867
pii:
doi:
Substances chimiques
Anti-Inflammatory Agents, Non-Steroidal
0
Antioxidants
0
homoorientin
A37342TIX1
Luteolin
KUX1ZNC9J2
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
104867Subventions
Organisme : FIC NIH HHS
ID : D43 TW010131
Pays : United States
Informations de copyright
Copyright © 2020 Elsevier Ltd. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of Competing Interest The authors declare no conflict of interest.